Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 24% ± 13% | |
basal cell | 7 studies | 28% ± 6% | |
fibroblast | 5 studies | 19% ± 2% | |
squamous epithelial cell | 3 studies | 43% ± 18% | |
placental villous trophoblast | 3 studies | 28% ± 9% | |
pericyte | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
prostate | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1973.06 | 653 / 653 | 100% | 65.32 | 604 / 605 |
breast | 100% | 991.30 | 458 / 459 | 100% | 36.36 | 1114 / 1118 |
skin | 100% | 3017.30 | 1809 / 1809 | 99% | 49.14 | 469 / 472 |
brain | 99% | 1016.58 | 2613 / 2642 | 100% | 32.60 | 705 / 705 |
esophagus | 100% | 979.17 | 1443 / 1445 | 99% | 44.13 | 181 / 183 |
adrenal gland | 100% | 1028.41 | 258 / 258 | 98% | 28.83 | 226 / 230 |
prostate | 98% | 522.32 | 239 / 245 | 99% | 22.93 | 497 / 502 |
kidney | 99% | 584.91 | 88 / 89 | 97% | 27.08 | 873 / 901 |
uterus | 95% | 616.88 | 161 / 170 | 99% | 42.09 | 455 / 459 |
lung | 94% | 661.74 | 545 / 578 | 99% | 39.91 | 1144 / 1155 |
liver | 97% | 609.46 | 219 / 226 | 92% | 15.16 | 372 / 406 |
bladder | 90% | 533.43 | 19 / 21 | 96% | 26.61 | 483 / 504 |
ovary | 86% | 396.99 | 154 / 180 | 100% | 28.70 | 430 / 430 |
intestine | 80% | 547.07 | 769 / 966 | 98% | 22.35 | 514 / 527 |
stomach | 68% | 429.06 | 245 / 359 | 97% | 22.00 | 278 / 286 |
pancreas | 66% | 221.79 | 216 / 328 | 96% | 22.10 | 170 / 178 |
tonsil | 0% | 0 | 0 / 0 | 100% | 48.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.53 | 1 / 1 |
adipose | 100% | 1029.55 | 1202 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 26.72 | 79 / 80 |
heart | 94% | 650.79 | 810 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 476.20 | 1223 / 1335 | 0% | 0 | 0 / 0 |
muscle | 90% | 460.55 | 726 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 11.63 | 22 / 29 |
spleen | 43% | 130.63 | 103 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 20% | 127.08 | 186 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0017017 | Molecular function | MAP kinase tyrosine/serine/threonine phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0003723 | Molecular function | RNA binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | DUSP14 |
Protein name | DUSP14 protein (Dual specificity phosphatase 14, isoform CRA_a) (cDNA, FLJ95796, Homo sapiens dual specificity phosphatase 14 (DUSP14), mRNA) Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48) (MKP-1-like protein tyrosine phosphatase) (MKP-L) (Mitogen-activated protein kinase phosphatase 6) (MAP kinase phosphatase 6) (MKP-6) |
Synonyms | hCG_28185 MKP6 |
Description | FUNCTION: Involved in the inactivation of MAP kinases. Dephosphorylates ERK, JNK and p38 MAP-kinases. Plays a negative role in TCR signaling by dephosphorylating MAP3K7 adapter TAB1 leading to its inactivation . . |
Accessions | ENST00000614294.2 ENST00000617516.5 O95147 ENST00000632468.1 ENST00000633870.1 ENST00000614411.1 ENST00000613659.1 Q6FI36 |